Structure
A dynamic, multi-disciplinary Board of prominent experts
The HPV Prevention and Control Board is composed of a group of experts as HPV Prevention and Control Board Advisers, who set the strategy and define the actions. The advisers are internationally recognised experts in the fields of HPV, HPV related cancer, public health, and vaccinology. They are able to offer high quality information and expert opinions to the target audiences of opinion leaders, policymakers, and health care professionals. They are professionally highly active in their fields of expertise, and will ensure that the HPV Prevention Board responds rapidly and effectively as new issues emerge. Apart from academia, and national health authorities, representatives from headquarters (WHO/HQ), the WHO regional office for Europe (WHO/EURO), IARC, GAVI, the International Papillomavirus Society (IPS), European Centre for Disease Control and Prevention (ECDC) and the US Centres for Disease Control and Prevention (CDC) are members of the board.
In addition to the permanent group of experts, external experts are invited on an ad hoc basis depending on the topics discussed at the meeting.
View the members of the Board
| Dr. Narendra Kumar Arora Global Executive Director INCLEN Trust International (INCLEN) India nkarora@inclentrust.org |
|
Prof. dr. Paolo Bonanni
Professor in Public Health Dipartimento di Scienze della Salute (DSS) University of Florence Italy paolo.bonanni@unifi.it |
|
Dr. Kate Cuschieri
Director Human Papillomavirus Research Group Reference Laboratory and Lead for HPV Research Group Scottish Human Papilloma Virus Reference Laboratory ( (SHPVRL) Royal Infirmary of Edinburgh NHS Lothian & (Honorary) HPV Research Group Centre for Reproductive Health University of Edinburgh Scotland, UK kate.cuschieri@nhslothian.scot.nhs.uk |
|
Dr. Silvia de Sanjosé
Consultant – National Cancer Institute (NCI) Senior Advisor to Women’s Cancer – PATH NCI, PATH International Papilloma Virus Society Spain & USA desanjosé.silvia@gmail.com |
|
Prof. dr. Eduardo Franco
Professor Department of Oncology and Department of Epidemiology & Biostatistics Director Division of Cancer Epidemiology Chairman Department of Oncology Faculty of Medicine McGill University Canada eduardo.franco@mcgill.ca |
|
Prof. dr. Suzanne Garland
Prof. Reproductive & Neonatal Infectious Diseases Department of Obstetrics and Gynaecology Director of the Centre for Women’s Infectious Diseases (WCID) Research Honorary Research Fellow, Infection & Immunity University of Melbourne The Royal Women’s Hospital, Melbourne Murdoch Children’s Research Institute, Melbourne Australia |
|
Dr. Anna Giuliano
Director Centre for Immunization and Infection Research in Cancer (CIIRC) Moffitt Cancer Centre USA |
|
Prof. dr. Murat Gultekin
MD, Associate. Prof., Gyneacological Oncologist, Chair Faculty of Medicine Hacettepe University ESGO Prevention and Advocacy Commitee Chair and ESGO ENGAGe Chair Turkey |
|
Dr. Sharon J.B. Hanley
Assistant Professor Hokkaido University for Environmental and Health Sciences Japan sjbh1810@med.hokudai.ac.jp |
|
Prof. dr. Mira Kojouharova
Former Deputy Director, Head National Centre of Infectious and Parasitic Diseases (NCIPD) Bulgaria mkojouharova@ncipd.org |
|
Prof. dr. Susanne Krüger Kjaer
Danish Cancer Society Research Center Unit of Virus, Lifestyle and Genes susanne@cancer.dk |
|
Dr. Heidi Larson
Professor of Anthropology, Risk and Decision Science Director of the Vaccine Confidence Project London School of Hygiene and Tropical Medicine (LSHTM) UK Heidi.Larson@lshtm.ac.uk |
|
Dr. Nelly Rwamba Mugo
Principal Clinical Research Scientist
Kenya Medical Research Institute
Research and Development
|
|
Dr. Nubia Muñoz
Emeritus Professor Instituto Nacional de Cancerología Bogota, Colombia |
|
Prof. dr. Mario Poljak
Head of the Laboratory for Molecular Microbiology and Slovenian HIV/AIDS and Hepatitis Reference Center Institute of Microbiology and Immunology Faculty of Medicine University of Ljubljana Slovenia mario.poljak@mf.uni-lj.si |
|
Prof. dr. Margaret Stanley
Director of Research Project: Pathogenesis of Human Papillomavirus Infections Department of Pathology University of Cambridge UK mas@mole.bio.cam.ac.uk |
|
Dr. Marc Steben
Groupe de médecine familiale La Cité du Parc Lafontaine Montréal, Canada |
|
Prof. dr. Pierre Van Damme
Director Centre for the Evaluation of Vaccination Vaccine & Infectious Disease Institute Faculty of Medicine University of Antwerp, Belgium pierre.vandamme@uantwerpen.be |
|
Prof. dr. ir. Alex Vorsters
Associated Professor Centre for the Evaluation of Vaccination Vaccine & Infectious Disease Institute Faculty of Medicine University of Antwerp Belgium alex.vorsters@uantwerpen.be |
|
Observers:
|
|
Dr. Liudmila Mosina
WHO Euro World Health Organization |
|
Dr. Rebecca Casey
Centre for Disease Control & Prevention (CDC)
Global Immunization Division
|
A flexible, experienced, and well-connected Executive Secretariat
The secretariat of the HPV Prevention Board is located at the University of Antwerp, at the Vaccine & Infectious Disease Institute, within the structure of the Centre for the Evaluation of Vaccination (CEV), which has 32 years of experience of successfully running the VHPB secretariat The CEV is a WHO Collaborating Centre for the Prevention and Control of Infectious Diseases.
View the secretariat team
The executive secretariat of the HPV prevention and control Board has its seat at VAXINFECTIO, Centre for the Evaluation of Vaccination at the University of Antwerp, Belgium. Team members are:
Prof. Dr. Ir. Alex Vorsters, alex.vorsters@uantwerpen.be
Prof. Dr. Pierre Van Damme, pierre.vandamme@uantwerpen.be
Mrs. Greet Hendrickx, greet.hendrickx@uantwerpen.be
Miss. Dur-e-Nayab Waheed, nayab.waheed@uantwerpen.be
Dr. Felix Ricardo Burdier Custodio, ricardo.burdier@uantwerpen.be
Dr. Sara Valckx, sara.valckx@uantwerpen.be
Mrs. Xenia Mikulla, xenia.mikulla@uantwerpen.be
Mrs. Brenda Janssens, brenda.janssens@uantwerpen.be